Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.

BACKGROUND and AIMS: Transforming growth factor beta and its intracellular mediators, Smad proteins, play important roles in stimulating collagen gene transcription and, thus, could be the targets for treating hepatic fibrosis. However, intervention of transforming growth factor beta/Smad signaling...

Full description

Bibliographic Details
Main Authors: Inagaki, Y, Kushida, M, Higashi, K, Itoh, J, Higashiyama, R, Hong, Y, Kawada, N, Namikawa, K, Kiyama, H, Bou-Gharios, G, Watanabe, T, Okazaki, I, Ikeda, K
Format: Journal article
Language:English
Published: 2005
_version_ 1797087336647884800
author Inagaki, Y
Kushida, M
Higashi, K
Itoh, J
Higashiyama, R
Hong, Y
Kawada, N
Namikawa, K
Kiyama, H
Bou-Gharios, G
Watanabe, T
Okazaki, I
Ikeda, K
author_facet Inagaki, Y
Kushida, M
Higashi, K
Itoh, J
Higashiyama, R
Hong, Y
Kawada, N
Namikawa, K
Kiyama, H
Bou-Gharios, G
Watanabe, T
Okazaki, I
Ikeda, K
author_sort Inagaki, Y
collection OXFORD
description BACKGROUND and AIMS: Transforming growth factor beta and its intracellular mediators, Smad proteins, play important roles in stimulating collagen gene transcription and, thus, could be the targets for treating hepatic fibrosis. However, intervention of transforming growth factor beta/Smad signaling affects physiological signal transduction as well and may cause serious adverse effects on clinical application. Here we have attempted to suppress hepatic fibrosis by expressing a transforming growth factor beta/Smad antagonist selectively in collagen-producing cells only in the fibrotic liver. METHODS: Recombinant adenoviruses expressing either green fluorescent protein or a transforming growth factor beta/Smad signal repressor, YB-1, were injected into mice untreated or treated with carbon tetrachloride. Green fluorescent protein expression was analyzed under a confocal laser scanning microscope. Antifibrotic effects of YB-1 overexpression were examined by luciferase assays and histological examination with transgenic reporter mice. RESULTS: When the CAG expression unit was used as a control, green fluorescent protein was strongly expressed in a large number of hepatocytes in both normal and carbon tetrachloride-treated liver. In contrast, green fluorescent protein expression driven by a tissue-specific enhancer of the mouse alpha2(I) collagen gene ( COL1A2 ) was detected in activated hepatic stellate cells in carbon tetrachloride-induced fibrotic liver, but not in untreated normal liver. No green fluorescent protein fluorescence was observed in any other organs when the COL1A2 enhancer was used. Adenovirus-mediated YB-1 expression under the control of the COL1A2 enhancer significantly decreased COL1A2 promoter activity after carbon tetrachloride injection and subsequently suppressed the progression of hepatic fibrosis. CONCLUSIONS: These results validate a new concept of the therapy for hepatic fibrosis to achieve cell type-specific gene expression only in the fibrotic liver, with little damage to other organs.
first_indexed 2024-03-07T02:34:21Z
format Journal article
id oxford-uuid:a84aa6e7-9d28-4614-86d2-e5847ec5868b
institution University of Oxford
language English
last_indexed 2024-03-07T02:34:21Z
publishDate 2005
record_format dspace
spelling oxford-uuid:a84aa6e7-9d28-4614-86d2-e5847ec5868b2022-03-27T03:00:26ZCell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a84aa6e7-9d28-4614-86d2-e5847ec5868bEnglishSymplectic Elements at Oxford2005Inagaki, YKushida, MHigashi, KItoh, JHigashiyama, RHong, YKawada, NNamikawa, KKiyama, HBou-Gharios, GWatanabe, TOkazaki, IIkeda, K BACKGROUND and AIMS: Transforming growth factor beta and its intracellular mediators, Smad proteins, play important roles in stimulating collagen gene transcription and, thus, could be the targets for treating hepatic fibrosis. However, intervention of transforming growth factor beta/Smad signaling affects physiological signal transduction as well and may cause serious adverse effects on clinical application. Here we have attempted to suppress hepatic fibrosis by expressing a transforming growth factor beta/Smad antagonist selectively in collagen-producing cells only in the fibrotic liver. METHODS: Recombinant adenoviruses expressing either green fluorescent protein or a transforming growth factor beta/Smad signal repressor, YB-1, were injected into mice untreated or treated with carbon tetrachloride. Green fluorescent protein expression was analyzed under a confocal laser scanning microscope. Antifibrotic effects of YB-1 overexpression were examined by luciferase assays and histological examination with transgenic reporter mice. RESULTS: When the CAG expression unit was used as a control, green fluorescent protein was strongly expressed in a large number of hepatocytes in both normal and carbon tetrachloride-treated liver. In contrast, green fluorescent protein expression driven by a tissue-specific enhancer of the mouse alpha2(I) collagen gene ( COL1A2 ) was detected in activated hepatic stellate cells in carbon tetrachloride-induced fibrotic liver, but not in untreated normal liver. No green fluorescent protein fluorescence was observed in any other organs when the COL1A2 enhancer was used. Adenovirus-mediated YB-1 expression under the control of the COL1A2 enhancer significantly decreased COL1A2 promoter activity after carbon tetrachloride injection and subsequently suppressed the progression of hepatic fibrosis. CONCLUSIONS: These results validate a new concept of the therapy for hepatic fibrosis to achieve cell type-specific gene expression only in the fibrotic liver, with little damage to other organs.
spellingShingle Inagaki, Y
Kushida, M
Higashi, K
Itoh, J
Higashiyama, R
Hong, Y
Kawada, N
Namikawa, K
Kiyama, H
Bou-Gharios, G
Watanabe, T
Okazaki, I
Ikeda, K
Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title_full Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title_fullStr Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title_full_unstemmed Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title_short Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
title_sort cell type specific intervention of transforming growth factor beta smad signaling suppresses collagen gene expression and hepatic fibrosis in mice
work_keys_str_mv AT inagakiy celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT kushidam celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT higashik celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT itohj celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT higashiyamar celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT hongy celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT kawadan celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT namikawak celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT kiyamah celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT boughariosg celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT watanabet celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT okazakii celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice
AT ikedak celltypespecificinterventionoftransforminggrowthfactorbetasmadsignalingsuppressescollagengeneexpressionandhepaticfibrosisinmice